Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
Top Cited Papers
Open Access
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (6) , 1008-1016
- https://doi.org/10.1038/mt.2011.65
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic VirotherapyMolecular Therapy, 2011
- Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral ImmunityMolecular Therapy, 2010
- Mumps and ovarian cancer: modern interpretation of an historic associationCancer Causes & Control, 2010
- Impact of tumor microenvironment on oncolytic viral therapyPublished by Elsevier ,2010
- Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyCancer Gene Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific ImmunotherapyMolecular Therapy, 2010
- Directing systemic oncolytic viral delivery to tumors via carrier cells☆Cytokine & Growth Factor Reviews, 2010
- Regulatory T Cells in CancerPublished by Elsevier ,2010
- Dendritic cells and innate defense against tumor cellsCytokine & Growth Factor Reviews, 2007